CyBio Remains on Course after First Six Months
(Thomson Reuters ONE) -
CyBio AG /
CyBio Remains on Course after First Six Months
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Jena (Germany), May 12, 2011 - CyBio AG (Deutsche Börse: General Standard, ISIN
DE0005412308) is closing the first six months of the current 2010/2011 financial
year with a pleasing increase in sales and earnings. The provider of solutions
for liquid handling processes generated consolidated sales revenues of EUR 6.2
million in the past six months (previous year: EUR 5.9 million) and was
therefore 4.8 % up on the same period of the previous year. The Thuringian
Company belonging to the Analytik Jena Group posted a significant increase in
its operating result (EBIT) compared with the previous financial year at EUR
1.0 million (previous year: EUR 0.4 million).
"Following the comprehensive restructuring over the past year we are very well
positioned in terms of costs," said Udo Werner, CEO of CyBio AG. "In the months
to come we will need to stabilize our business and sales figures and create
renewed growth prospects with innovative products. We are currently working on
this at full speed."
1. Sales and Segments
The greatest share of overall sales was achieved by CyBio AG itself (71.5 %). It
should be borne in mind here that these sales also include the business in Japan
previously handled by CyBio Japan Co., Ltd. CyBio US, Inc. contributed 24.7 % to
overall sales and CyBio NE Ltd. 3.8 %. In the UK the continued migration of
traditional CyBio customers above all to the Far East made itself particularly
felt.
Sales with equipment and equipment adaptations came to a positive figure of
almost EUR 3.3 million in the first six months of the financial year and
accordingly rose back above the mark of 50.0 % of total sales. The stable sales
in the service business (EUR 1.3 million) and with consumables (EUR 1.6 million)
also contributed to a good business performance.
2. Financial Situation
With an operating result of EUR 1.0 million (previous year: EUR 0.4 million) and
earnings before tax (EBT) of EUR 0.7 million (previous year: EUR 0.1 million),
CyBio achieved a result for the six-month period that was well above budget. The
successes from the cost reduction program and consistent cost management made a
significant contribution to this.
Liquid funds as at the reporting date of March 31, 2011 totaled EUR 2.5 million,
thus exceeding both the March 31, 2010 figure (EUR 1.8 million) and that of
September 30, 2010 (EUR 2.1 million).
3. Business Trend and Outlook
For the 2010/2011 financial year CyBio AG expects consolidated revenues between
EUR 10.5 million and EUR 11.5 million. The traditionally less active months of
the financial year in terms of sales lie before the Company, something that is
at present already reflected in reduced order expectations. However, owing to
the good result for the first six months the Company continues to expect an
operating result of around EUR 0.5 million and hence within the scope of the
previous year's level.
Contact:
CyBio AG
Investor Relations
Göschwitzer Str. 40
07745 Jena
Germany
Phone +49 (0)3641.351 495
Fax +49 (0)3641.351 409
E-mail: irpr(at)cybio-ag.com
--- End of Message ---
CyBio AG
Göschwitzer Straße 40 Jena Germany
WKN: 541230;ISIN: DE0005412308;Index:CDAX;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
General Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CyBio AG via Thomson Reuters ONE
[HUG#1514898]
Unternehmensinformation / Kurzprofil:
Datum: 12.05.2011 - 07:04 Uhr
Sprache: Deutsch
News-ID 54563
Anzahl Zeichen: 4744
contact information:
Town:
Jena
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 205 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CyBio Remains on Course after First Six Months"
steht unter der journalistisch-redaktionellen Verantwortung von
CyBio AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
